Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Lottosi
company
About
Lottosi is a developer of sewage biochemical treatment technology.
- Nanjing,Jiangsu,China
- 51 - 100
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥50M
- Industries
- Pollution Control,Waste Management,Water Purification
- Founded date
- Mar 6, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- Nanjing Letosco New Material Technology Co., Ltd.
- Also Known As
- Lotus
Nanjing Letosco New Material Technology Co., Ltd. is a rapidly expanding national high-tech company. The company is dedicated to the development, manufacturing, and joint promotion of new materials, technologies, and equipment in the field of environmental protection. It delivers one-stop environmental problem-solving services to the entire society, with innovative research and development as the driving force.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥50M
Lottosi has raised a total of
¥50M
in funding over 2 rounds. Their latest funding was raised on
Nov 30, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | Series A | ¥50M | 1 |
CMBC Capital Holdings
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Lottosi is funded by 1 investors.
CMBC Capital Holdings
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CMBC Capital Holdings
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
